143842-75-5

Usage

Explanation

The compound consists of 18 carbon atoms, 26 hydrogen atoms, and 2 oxygen atoms.

Explanation

The total mass of the molecule, calculated from the atomic weights of its constituent elements.

Explanation

The compound contains a combination of three-membered and five-membered rings, which are characteristic of the oxaspiro[4.5]decane core.

Explanation

A methyl group (CH3) is present in the molecule, contributing to its structure and potential reactivity.

Explanation

The phenylmethoxy group is a functional group present in the molecule, consisting of a benzene ring connected to a methoxy group, which may influence the compound's properties and applications.

Explanation

Due to its unique structure and functional groups, the compound may have potential applications in the pharmaceutical or agrochemical industries, although further research and analysis are required to determine its specific uses.

Explanation

The compound's complex structure, featuring a spiro ring system, methyl group, and phenylmethoxy group, may contribute to its unique properties and potential applications.

Molecular Weight

274.40 g/mol

Spiro Ring System

A central carbon atom shared by two rings

Cyclic Structure

Threeand five-membered rings

Methyl Group

A CH3 group attached to a carbon atom

Phenylmethoxy Group

A benzene ring linked to a methoxy group (OCH3)

Potential Applications

Pharmaceutical or Agrochemical Industries

Structural Complexity

Complex structure with multiple functional groups

Upstream product

• 81927-55-1 O-benzyl 2,2,2-trichloroacetimidate 
• 143842-74-4 <3R-<3α,5α(S^*)>>-8-methyl-3-(phenylmethoxy)-1-oxaspiro<4.5>dec-6-en-2-one 

Downstream Products

• 143842-76-6 (1S,4S)-1-((R)-2-Benzyloxy-but-3-enyl)-4-methyl-cyclohex-2-enol 
• 143842-93-7 (S)-2-Methyl-butyric acid (1aS,3S,4S,4aS,5S,7S,8aR)-7-(tert-butyl-diphenyl-silanyloxy)-4-{2-[(2R,4R)-4-(tert-butyl-diphenyl-silanyloxy)-6-oxo-tetrahydro-pyran-2-yl]-ethyl}-3-methyl-octahydro-1-oxa-cyclopropa[d]naphthalen-5-yl ester 
• 143842-95-9 (S)-2-Methyl-butyric acid (1S,3S,7S,8S,8aR)-3-(tert-butyl-diphenyl-silanyloxy)-8-{2-[(2R,4R)-4-(tert-butyl-diphenyl-silanyloxy)-6-oxo-tetrahydro-pyran-2-yl]-ethyl}-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester 
• 143842-94-8 (S)-2-Methyl-butyric acid (1S,3S,5S,7S,8S,8aR)-3-(tert-butyl-diphenyl-silanyloxy)-8-{2-[(2R,4R)-4-(tert-butyl-diphenyl-silanyloxy)-6-oxo-tetrahydro-pyran-2-yl]-ethyl}-5-hydroxy-7-methyl-1,2,3,5,6,7,8,8a-octahydro-naphthalen-1-yl ester 
• 143842-92-6 (S)-2-Methyl-butyric acid (1aS,3S,4S,4aS,5S,7S,8aR)-7-(tert-butyl-diphenyl-silanyloxy)-4-{2-[(2R,4R,6S)-4-(tert-butyl-diphenyl-silanyloxy)-6-methoxy-tetrahydro-pyran-2-yl]-ethyl}-3-methyl-octahydro-1-oxa-cyclopropa[d]naphthalen-5-yl ester 
• 143842-91-5 (1aS,3S,4S,4aS,5S,7S,8aR)-7-(tert-Butyl-diphenyl-silanyloxy)-4-{2-[(2R,4R,6S)-4-(tert-butyl-diphenyl-silanyloxy)-6-methoxy-tetrahydro-pyran-2-yl]-ethyl}-3-methyl-octahydro-1-oxa-cyclopropa[d]naphthalen-5-ol 
• 143857-20-9 (1S,3R,7S,8S,8aR)-3-(tert-Butyl-diphenyl-silanyloxy)-8-{2-[(2R,4R,6S)-4-(tert-butyl-diphenyl-silanyloxy)-6-methoxy-tetrahydro-pyran-2-yl]-ethyl}-7-methyl-1,2,3,4,6,7,8,8a-octahydro-naphthalen-1-ol 
• 143842-81-3 <1S-<1α,2α,6α,8β,8aα>>-1,2,3,5,6,7,8,8a-octahydro-N,N,2-trimethyl-6-(phenylmethoxy)-8-<(trimethylsilyl)oxy>-1-naphthaleneacetamide 
• 143842-80-2 <1S-<1α,2α,6α,8β,8aα>>-1,2,3,5,6,7,8,8a-octahydro-8-hydroxy-N,N,2-trimethyl-6-(phenylmethoxy)-1-naphthaleneacetamide 
• 143842-78-8 <1S-<1α,3(S^*),6α>>-3-<4-hydroxy-2-(phenylmethoxy)butyl>-N,N,6-trimethyl-2-cyclohexene-1-acetamide 
• 143842-79-9 2-[(1S,6S)-3-((R)-2-Benzyloxy-4-oxo-butyl)-6-methyl-cyclohex-2-enyl]-N,N-dimethyl-acetamide 
• 143842-77-7 <1S-<1α,3(S^*),6α>>-3-<2-(phenylmethoxy)-3-butenyl>-N,N,6-trimethyl-2-cyclohexene-1-acetamide 
• 85956-22-5 pravastatin lactone